G4766E108

Indivior Pharmaceuticals, Inc.

Could not find a ticker for this position, may be a filing error

A specialty pharmaceutical company focused on treating opioid addiction, Indivior makes Suboxone (a film that dissolves under the tongue) and Sublocade (a once-monthly injection) to help people recover, plus Opvee, a nasal spray that reverses opioid overdoses. It began in 1994 as a buprenorphine unit inside consumer-goods giant Reckitt Benckiser, then spun off in 2014 to become its own company. Its name is widely read as a nod to "individual" recovery—caring for the person, not just the condition.